Sort
50,496 grants matching “lung cancer”
Application of RiboTag-seq to Exploration of Tumor Microenvironments
$876,552David R Morris · University Of Washington · RC2 · FY2010 · CA
HFH-MSU CSRN ACCrual Enrollment and Screening Site
$876,366Christine Marie Neslund-Dudas · Henry Ford Health + Michigan State University Health Sciences · UG1 · FY2025 · CA
TAS::75 0872:: LUNG TISSUE RESEARCH CONSORTIUM: TISSUE REPOSITORY
$876,175Diane Sullivan · National Jewish Health · N01 · FY2013 · HL
THE GENETICS OF VULNERABILITY TO NICOTINE ADDICTIONS
$876,081Pamela Ann Madden · Washington University · R01 · FY2010 · DA
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer
$875,957Mary Christine Playdon · Utah State Higher Education System--University Of Utah · U01 · FY2025 · CA
The Study of HIV Infection in the Etiology of Lung Disease (SHIELD)
$875,872Gregory D Kirk · Johns Hopkins University · R01 · FY2011 · HL
Preventing Anthracycline Cardiovascular Toxicity with Statins
$875,689William Gregory Hundley · Wake Forest University Health Sciences · R01 · FY2014 · HL
Spectrally resolved tomographic small-animal fluorescence imager
$875,689Richard M. Levenson · Cambridge Research And Instrumentation · R44 · FY2009 · CA
Preclinical development of TIMP-2 as a biologic therapy for cancer
$875,665William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Colorectal Cancer Transcriptome: Effects of Genomic Instability and Aneuploidy
$875,644Thomas Ried · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Infections, immunity, and inflammation in cancer
$875,117Eric A Engels · Cancer Epidemiology And Genetics · Z01 · FY2007 · CA
Defining the features of T cell response to tumor and self-antigens as predictors of response to checkpoint therapy
$874,780Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason · R01 · FY2019 · CA
Biomarkers and mechanisms in cancer associated thrombosis
$874,736Jeffrey Zwicker · Beth Israel Deaconess Medical Center · U01 · FY2021 · HL
Biomarkers and mechanisms in cancer associated thrombosis
$874,736Jeffrey Zwicker · Beth Israel Deaconess Medical Center · U01 · FY2019 · HL
Biomarkers and mechanisms in cancer associated thrombosis
$874,736Jeffrey Zwicker · Beth Israel Deaconess Medical Center · U01 · FY2020 · HL
Building equity in cancer screening through research: The Siteman Catchment CSRN Hub
$874,688Aimee S James · Washington University · UG1 · FY2025 · CA
Building equity in cancer screening through research: The Siteman Catchment CSRN Hub
$874,686Aimee S James · Washington University · UG1 · FY2024 · CA
A rapid label-free sensor for immune markers of environmental exposure for applic
$874,681Christopher Striemer · Adarza Biosystems, Inc. · R44 · FY2010 · ES
Treating non-small cell lung tumors with a novel inhaled dry powder chemotherapeutic formulation
$874,452Bryce Beverlin II · Quench Medical, Inc. · R44 · FY2024 · CA
TGF-betas in breast cancer progression
$874,425Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Improving lung cancer surgery with an intraoperative, tumor-targeted, activatable fluorescent imaging agent
$874,253Eric Scott Bensen · Vergent Bioscience, Inc. · R44 · FY2023 · CA
Non-Invasive Pneumothorax Detector
$874,027Daniel N Kelsch · Electrosonics Medical Inc. · R44 · FY2007 · HL
Advancing Geriatrics Infrastructure & Network Growth
$873,570Jerry H Gurwitz · Univ Of Massachusetts Med Sch Worcester · R24 · FY2016 · AG
SINGAPORE COHORT STUDY OF DIET AND CANCER
$873,529University Of Southern California · R01 · FY2002 · CA
Clinical Cancer Cytogenetics
$873,396Diane C Arthur · Division Of Basic Sciences - Nci · ZID · FY2014 · CA